专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明公开

EP1673125A1 SYSTEM AND METHOD FOR DELIVERING A SUBSTANCE TO A BODY CAVITY 有权转让
标题翻译： SYSTEM FOR A物质于一体的CAVE供应
公开(公告)号：EP1673125A1
公开(公告)日：2006-06-28
申请号：EP04794396.4
申请日：2004-10-07
申请人： Northgate Technologies Incorporated
发明人： MANTELL, Robert, R.
IPC分类号： A61M13/00 , A61M11/00
CPC分类号： A61M13/003 , A61B17/3474 , A61M2202/0241 , A61M2202/0468 , A61M2210/1017
摘要： A system (10) and method for creating a medicated atmosphere in an organ, or body cavity is disclosed. The system includes a flexible aerosolizatìon catheter (22) that can be manipulated during use, a device (23) for the introduction of the aerosolization catheter, a medication delivery apparatus (16) configured to control delivery of a medication to the catheter, a gas delivery apparatus (14) in communication with the catheter, a gas pressure relief apparatus (25) configured to relieve pressure in the organ or body cavity, and a central controller (130) in communication with the medication delivery apparatus, gas delivery apparatus, and gas pressure relief apparatus control of the various means. The method includes providing insufflation gas and an aerosol of medication to an organ or body cavity while controlling overall pressure in the organ or cavity.

32. 发明公开

EP0177577A4 INTERNAL DIALYZER WITH WEARABLE EXTERNAL REGENERATION. 无效
标题翻译：内部透析PORTABLE AUSWENDIGER再生。
公开(公告)号：EP0177577A4
公开(公告)日：1987-04-07
申请号：EP85901841
申请日：1985-03-26
申请人： RES DEV SYSTEMS
发明人： SCOTT ROBERT D
IPC分类号： A61M1/16 , A61M1/28
CPC分类号： A61M1/1696 , A61M1/1678 , A61M1/28 , A61M1/284 , A61M2209/088 , A61M2210/1017

33. 发明公开

EP3009077A4 PNEUMOPERITONEUM APPARATUS 无效转让
标题翻译： PNEUMOPERITONEUMVORRICHTUNG
公开(公告)号：EP3009077A4
公开(公告)日：2017-02-15
申请号：EP14835141
申请日：2014-06-05
申请人： OLYMPUS CORP
发明人： HIRAGA KUNITOSHI , FURUKAWA NOBUYUKI
IPC分类号： A61B17/00 , A61B1/00 , A61B1/015 , A61B1/04 , A61B1/06 , A61B1/313 , A61M13/00
CPC分类号： A61M13/006 , A61B1/015 , A61B1/3132 , A61M2202/0225 , A61M2205/3334 , A61M2205/3344 , A61M2205/75 , A61M2210/1017 , A61M2202/0007

34. 发明公开

EP3011984A1 EXTRACORPOREAL DIALYSIS READY PERITONEAL DIALYSIS MACHINE 审中-实审
标题翻译： BETREBSBEREITE PERITONEALDIALYSEMASCHINEFÜREXTRAKORPORALE DIALYSE
公开(公告)号：EP3011984A1
公开(公告)日：2016-04-27
申请号：EP15198114.9
申请日：2008-07-02
申请人： Baxter International Inc. , Baxter Healthcare S.A.
发明人： Cicchello, Gino , Bernard, Christian , Childers, Robert , Simiele, Anthony
IPC分类号： A61M1/16 , A61M1/34
CPC分类号： A61M1/282 , A61M1/1039 , A61M1/16 , A61M1/1601 , A61M1/1603 , A61M1/1611 , A61M1/1639 , A61M1/168 , A61M1/1682 , A61M1/1686 , A61M1/1688 , A61M1/169 , A61M1/1694 , A61M1/1696 , A61M1/28 , A61M1/284 , A61M1/288 , A61M1/30 , A61M1/34 , A61M1/3417 , A61M1/3427 , A61M1/3431 , A61M1/3437 , A61M1/3444 , A61M2205/12 , A61M2205/128 , A61M2205/3331 , A61M2205/3344 , A61M2205/3368 , A61M2205/3379 , A61M2205/50 , A61M2205/502 , A61M2210/1017
摘要： A combined blood treatment and peritoneal dialysis ("PD") system is described. The system comprises: a peritoneal dialysis (PD) unit (20); a blood treatment unit (40); a control unit (26, 46) with memory; and a user interface that operates with the control unit. The control unit is programmed to: (i) determine whether a previous PD treatment left a last fill of dialysate in a patient's peritoneum; (ii) if a next treatment is a PD treatment cause the user interface to provide a PD setup procedure and if the previous treatment did not leave the last fill of dialysate in the patient's peritoneum, implement a PD treatment in which a first cycle is a fill cycle; (iii) if a next treatment is a PD treatment cause the user interface to provide a PD setup procedure and if the previous treatment did leave the last fill of dialysate in the patient's peritoneum, implement a PD treatment in which a first cycle is a last fill drain cycle; (iv) if a next treatment is a blood treatment cause the user interface to provide a blood treatment setup procedure and if the previous PD treatment did leave the last fill of dialysate in the patient's peritoneum, implement a blood treatment that includes a last fill drain cycle; and (v) if a next treatment is a blood treatment cause the user interface to provide a blood treatment setup procedure and if the previous PD treatment did not leave the last fill of dialysate in the patient's peritoneum, implement a blood treatment that does not include a last fill drain cycle.
摘要翻译：描述了联合血液处理和腹膜透析（“PD”）系统。该系统包括：腹膜透析（PD）单元（20）; 血液处理单元（40）; 具有存储器的控制单元（26,46）; 以及与控制单元一起操作的用户界面。控制单元被编程为：（i）确定先前的PD治疗是否在患者的腹膜中留下最后一次填充透析液; （ii）如果接下来的治疗是PD治疗导致用户界面提供PD设置程序，并且如果先前的治疗没有在患者腹膜中留下透析液的最后填充，则实施PD治疗，其中第一周期是填充循环; （iii）如果接下来的治疗是PD治疗导致用户界面提供PD设置程序，并且如果先前的治疗确实在患者腹膜中留下了透析液的最后一次填充，则实施PD治疗，其中第一周期是最后的填充排水循环; （iv）如果接下来的治疗是血液处理，则导致用户界面提供血液处理设置程序，并且如果先前的PD治疗确实在患者的腹膜中离开了最后一次透析液填充，则执行包括最后一次排水的血液处理周期; 和（v）如果接下来的治疗是血液处理导致用户界面提供血液处理设置程序，并且如果先前的PD治疗没有在患者腹膜中留下透析液的最后一次填充，则实施不包括的血液处理最后一个填充排水循环。

35. 发明公开

EP2858569A1 SYSTEM AND METHOD OF MONITORING AND CONTROL OF ULTRAFILTRATION VOLUME DURING PERITONEAL DIALYSIS USING SEGMENTAL BIOIMPEDANCE 有权
标题翻译：系统ZURÜBERWACHUNGUND STEUERUNG VON ULTRAFILTRATIONSVOLUMINAWÄHRENDEINER PERITONEALDIALYSE MITTELS SEGMENTALER BIOIMPEDANZ
公开(公告)号：EP2858569A1
公开(公告)日：2015-04-15
申请号：EP13800441.1
申请日：2013-06-07
申请人： Fresenius Medical Care Holdings, Inc.
发明人： ZHU, Fansan , LEVIN, Nathan, W.
IPC分类号： A61B5/1455 , A61B5/00 , A61B5/05 , A61B6/00 , A61M1/14 , A61M1/28 , A61M5/142 , G01N21/35
CPC分类号： A61M1/28 , A61B5/1451 , A61B5/4848 , A61B5/6866 , A61M1/281 , A61M1/282 , A61M1/284 , A61M2205/17 , A61M2205/18 , A61M2205/3317 , A61M2205/3344 , A61M2205/3379 , A61M2205/3569 , A61M2205/3592 , A61M2210/1017 , A61M2230/005
摘要： A peritoneal dialysis (PD) system for infusing a volume of PD solution into a patient's peritoneal cavity in order to perform peritoneal dialysis on the patient includes a peritoneal cavity monitor (PCM) that measures this volume of fluid in the patient's peritoneal cavity by segmental bioimpedance spectroscopy (SBIS), to thereby determine an ultrafiltration volume of fluid in the patient's peritoneal cavity, and a switch, controlled by the PCM, for filling the patient's peritoneal cavity and draining the patient's peritoneal cavity when the ultrafiltration volume is unchanged over time, significantly decreased, or decreasing at a significant rate.
摘要翻译：腹膜透析（PD）系统，用于将一定体积的PD溶液注入到患者的腹膜腔中以便对患者进行腹膜透析包括腹膜腔监测器（PCM），其通过分段生物阻抗来测量患者腹膜腔内的这种体积的流体光谱学（SBIS），从而确定患者腹膜腔中的液体的超滤体积，以及由PCM控制的开关，用于填充患者的腹膜腔，并且当超滤体积随着时间的推移不变时排出患者的腹膜腔减少或显着降低。

36. 发明公开

EP2814537A1 SYSTEMS AND METHODS FOR TREATING CHRONIC LIVER FAILURE BASED ON PERITIONEAL DIALYSIS 有权转让
标题翻译：系统和方法慢性肝功不全基于透析PERITIONEALER的治疗
公开(公告)号：EP2814537A1
公开(公告)日：2014-12-24
申请号：EP12818674.9
申请日：2012-02-15
申请人： Sequana Medical AG
发明人： DEGEN, Thomas , THOMMEN, Daniel , JOHNSON, Noel, L.
IPC分类号： A61M1/28
CPC分类号： A61M1/28 , A61M1/1676 , A61M1/1678 , A61M1/281 , A61M1/285 , A61M1/288 , A61M2205/04 , A61M2205/3507 , A61M2205/3569 , A61M2205/50 , A61M2205/52 , A61M2205/8206 , A61M2205/8243 , A61M2210/1017 , A61M2210/1071 , A61M2210/1085
摘要： An artificial liver system for treating liver failure includes a reservoir to provide albumin-containing dialysis fluid to the patient's peritoneum, an implantable device including a pump to pump the fluid from the peritoneum to the bladder via respective catheters, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve data reflective of the patient's health; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The monitoring and control software allows a treating physician to remotely adjust the volume, time, and frequency with which fluid is pumped from the peritoneal cavity to the bladder based on the data reflective of the patient's health.
摘要翻译：用于治疗肝功能衰竭的人造肝系统包括贮存器，以提供含白蛋白的透析液给患者的腹膜，可植入装置，其包括泵，用于从腹膜经由respectivement导管，控制电路，电池和收发器膀胱泵送流体; 配置为周期性地对电池充电并与该可植入装置，以检索反映患者健康的数据通信的充电与通信系统; 和监测和控制软件，适合于与传统的个人计算机，配置和控制操作的可植入装置的与充电和通信系统中使用。监测和控制软件允许治疗医生来远程调节音量，时间，并与哪个频率流体从腹膜腔泵送到基于反射患者的健康的数据膀胱。

37. 发明公开

EP2167159A2 EXTRACORPOREAL DIALYSIS READY PERITONEAL DIALYSIS MACHINE 有权转让
标题翻译：。。。。。。。。。。。。
公开(公告)号：EP2167159A2
公开(公告)日：2010-03-31
申请号：EP08772323.5
申请日：2008-07-02
申请人： Baxter International Inc. , Baxter Healthcare S.A.
发明人： CICCHELLO, Gino , BERNARD, Christian , CHILDERS, Robert , SIMIELE, Anthony
IPC分类号： A61M1/16 , A61M1/34
CPC分类号： A61M1/282 , A61M1/1039 , A61M1/16 , A61M1/1601 , A61M1/1603 , A61M1/1611 , A61M1/1639 , A61M1/168 , A61M1/1682 , A61M1/1686 , A61M1/1688 , A61M1/169 , A61M1/1694 , A61M1/1696 , A61M1/28 , A61M1/284 , A61M1/288 , A61M1/30 , A61M1/34 , A61M1/3417 , A61M1/3427 , A61M1/3431 , A61M1/3437 , A61M1/3444 , A61M2205/12 , A61M2205/128 , A61M2205/3331 , A61M2205/3344 , A61M2205/3368 , A61M2205/3379 , A61M2205/50 , A61M2205/502 , A61M2210/1017
摘要： A combined blood treatment and peritoneal dialysis ("PD") system is described. The system comprises: a peritoneal dialysis (PD) unit (20); a blood treatment unit (40); a control unit (26, 46) with memory; and a user interface that operates with the control unit. The control unit is programmed to: (i) determine whether a previous PD treatment left a last fill of dialysate in a patient's peritoneum; (ii) if a next treatment is a PD treatment cause the user interface to provide a PD setup procedure and if the previous treatment did not leave the last fill of dialysate in the patient's peritoneum, implement a PD treatment in which a first cycle is a fill cycle; (iii) if a next treatment is a PD treatment cause the user interface to provide a PD setup procedure and if the previous treatment did leave the last fill of dialysate in the patient's peritoneum, implement a PD treatment in which a first cycle is a last fill drain cycle; (iv) if a next treatment is a blood treatment cause the user interface to provide a blood treatment setup procedure and if the previous PD treatment did leave the last fill of dialysate in the patient's peritoneum, implement a blood treatment that includes a last fill drain cycle; and (v) if a next treatment is a blood treatment cause the user interface to provide a blood treatment setup procedure and if the previous PD treatment did not leave the last fill of dialysate in the patient's peritoneum, implement a blood treatment that does not include a last fill drain cycle.
摘要翻译：描述了联合血液处理和腹膜透析（“PD”）系统。该系统包括：腹膜透析（PD）单元（20）; 血液处理单元（40）; 具有存储器的控制单元（26,46）; 以及与控制单元一起操作的用户界面。控制单元被编程为：（i）确定先前的PD治疗是否在患者的腹膜中留下最后一次填充透析液; （ii）如果接下来的治疗是PD治疗导致用户界面提供PD设置程序，并且如果先前的治疗没有在患者腹膜中留下透析液的最后一次填充，则实施PD治疗，其中第一周期是填充循环; （iii）如果接下来的治疗是PD治疗导致用户界面提供PD设置程序，并且如果先前的治疗确实在患者腹膜中留下了透析液的最后一次填充，则实施PD治疗，其中第一周期是最后的填充排水循环; （iv）如果接下来的治疗是血液处理，则导致用户界面提供血液处理设置程序，并且如果先前的PD治疗确实在患者的腹膜中离开了最后一次透析液填充，则执行包括最后一次排水的血液处理周期; 和（v）如果接下来的治疗是血液处理导致用户界面提供血液处理设置程序，并且如果先前的PD治疗没有在患者腹膜中留下透析液的最后一次填充，则实施不包括的血液处理最后一个填充排水循环。

38. 发明授权

EP1673125B1 SYSTEM FOR DELIVERING A SUBSTANCE TO A BODY CAVITY 有权转让
标题翻译： SYSTEM FOR A物质于一体的CAVE供应
公开(公告)号：EP1673125B1
公开(公告)日：2009-12-23
申请号：EP04794396.4
申请日：2004-10-07
申请人： Northgate Technologies Incorporated
发明人： MANTELL, Robert, R.
IPC分类号： A61M13/00 , A61M11/00
CPC分类号： A61M13/003 , A61B17/3474 , A61M2202/0241 , A61M2202/0468 , A61M2210/1017

39. 发明公开

EP1420851A4 USE OF A BLOOD-FLOW DECREASE PREVENTING AGENT IN CONJUNCTION WITH INSUFFLATING GAS 有权
标题翻译：使用一个MITTELSD防止血液流量减少与吹气连接
公开(公告)号：EP1420851A4
公开(公告)日：2008-12-31
申请号：EP02746630
申请日：2002-07-12
申请人： UNIV DUKE
发明人： STAMLER JONATHAN S
IPC分类号： A61B19/00 , A61K31/21 , A61B17/34 , A61K9/12 , A61K33/00 , A61K45/00 , A61M31/00 , A61P9/10
CPC分类号： A61K33/00 , A61B17/34 , A61B17/3474 , A61K31/04 , A61K31/21 , A61M31/00 , A61M2202/02 , A61M2210/1017 , A61K2300/00

40. 发明公开

EP1420851A1 USE OF A BLOOD-FLOW DECREASE PREVENTING AGENT IN CONJUNCTION WITH INSUFFLATING GAS 有权
标题翻译： A的使用手段去阻止血液流量减少与吹气连接
公开(公告)号：EP1420851A1
公开(公告)日：2004-05-26
申请号：EP02746630.9
申请日：2002-07-12
申请人： DUKE UNIVERSITY
发明人： STAMLER, Jonathan, S.
IPC分类号： A61M31/00
CPC分类号： A61K33/00 , A61B17/34 , A61B17/3474 , A61K31/04 , A61K31/21 , A61M31/00 , A61M2202/02 , A61M2210/1017 , A61K2300/00
摘要： A blood-flow decrease preventing agent is used to negate or reduce the decreased oxygen delivery in abdominal organs caused by insufflating gas. Preferably a gas is delivered into the abdominal cavity consisting essentially of the insufflating gas and the blood-flow decrease preventing agent. Very preferably, a gas is used consisting essentially of carbon dioxide as the insufflating gas and ethyl nitrite as the blood-flow to abdominal organ decrease preventing agent.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式